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THE anti-inflammatory effect of microalgae Spirulina
was  studied  in  zymosan-induced  arthritis  in  mice.
Four days after the intra-articular injection of zymo-
san  (15mg/ml),  Spirulina  (100  and  400mg/kg  per-
orally) was administered to animals for 8 days. The
mice  were  than  killed  and  b -glucuronidase  was
measured in the synovial fluid. Each knee joint was
totally  removed  for  histopathological  studies.  Spir-
ulina  significantly  reduced  the  levels  of  b -glucur-
onidase that had been increased by zymosan. Histo-
pathological  and  ultrastructural  studies  showed
inhibition of the inflammatory reaction, whereas no
destruction  of  cartilage,  well-preserved  chondro-
cytes, and normal rough endoplasmic reticulum and
mitochondria  were  seen.  The  anti-arthritic  effect
exerted by Spirulina as shown in this model may be at
least  partly  due  to  the  previously  reported  anti-
inflammatory  and  antioxidative  properties  of  its
constituent, phycocyanin. To our knowledge, this is
the  first  report  on  the  anti-inflammatory  effect  of
Spirulina in an experimental model of arthritis.
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Introduction
Spirulina  is  an  unbranched,  helicoidal,  filamentous
blue green algae or cyanobacterium that has a long
history of use as food. There are reports that Spirulina
was used traditionally by Mexicans during the Aztec
civilization for over 1000 years and also used as food
by the natives in the Lake Chad Area.1 Early interest in
Spirulina focused mainly on its potential as a source of
protein and vitamins, but recently more attention has
been made to study its therapeutic use, and a number
of published reports suggest beneficial effects of this
microalgae  in  hypertension,  its  anti-cancer  and
immune  suppressing  actions,2–4 and its  antioxidant
properties.5
Recently, we reported that phycocyanin, a bilipro-
tein  found  in  Spirulina,  exerts  a  scavenging  action
against reactive oxygen species (ROS) as well as anti-
inflammatory  activity  demonstrated  in  various  in
vitro and in vivo models.6–8
Furthermore, phycocyanin also exerted anti-inflam-
matory and anti-arthritic effects in zymosan-induced
arthritis  in  mice.9 Taking  into  account  the  former
findings  and the  fact that phycocyanin is  the most
abundant  pigment  of  Spirulina  that  represents
approximately 20% of algal dry weight,10 we decided
to  elucidate  whether  Spirulina  may  exert  similar
inhibitory  effects  in  this  zymosan-induced  arthritis
model as that observed for phycocyanin.
Materials and methods
Animals
Female 6-week-old OF1 mice from National Center for
Production  of  Laboratory  Animals  (CENPALAB,
Havana, Cuba)  were  used  in  this  study. They  were
housed  under  a  12h  light–dark  cycle  with  room
temperature maintained at 23°C, humidity at 55%, and
food and water available ad libitum. The experiments
were  conducted  in  accordance  with  the  ethical
guidelines for investigations in laboratory animals and
were approved by the Ethical Committee for Animal
Experimentation of the National Center for Scientific
Research. All reagents not specifically described were
purchased from Sigma (St Louis, MO, USA). Microalgae
Spirulina available with the trade name Spirulan was
kindly provided by Genix Enterprise (Havana, Cuba).
Zymosan-induced arthritis in mice
The mice (10 per group) were injected intra-articularly
with  10ml  of  a  15mg/ml  sterile  suspension  of
zymosan.11 Four days after zymosan injection, a water
suspension  of  Spirulina  (100  and  400mg/kg)  or
triamcinolone  (10mg/kg),  which  was  used  as  a
reference drug,  were administered orally  on a daily
basis, from days 4  to 12. Mice were then killed by
cervical dislocation and the synovial fluid of knee joints
was sampled to measure the level of b-glucuronidase
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removed for histological and ultrastructural studies.
Appropriate  controls  of  mice  only  treated  with
Spirulina and the vehicle were used.
Determination of b-glucuronidase activity
b-Glucuronidase activity was measured in the synovial
fluid of knee joints of mice.12 The patellar ligament
was  cut  and  the  synovial  cavity  incised,  the  total
synovial fluid was then absorbed by means of small
pieces of filter paper (No. 1575; Prolabo). The paper
tips  impregnated  with  synovial  fluid  were  cut  and
deposited at the bottom of tubes containing 0.9ml of
50 mM  acetate  buffer  (pH  4.5).  The  enzyme  was
measured in presence of its substrate (phenolphthal-
ein mono-b-glucuronic acid, 20 mM), after incubation
for  17h  at  37°C. Then  2.5vol  of  200 mM  glycine
buffer (pH 10.45) was added to induce the coloration
of  the phenolphthalein produced by the enzymatic
cleavage  of  the  substrate.  Samples  were  read  at
540nm, the coloration being stable for at least 1h.
Titers  were  based  on  comparisons  with  standard
curves obtained with b-glucuronidase (type B–1 from
bovine  liver). The  values  are  expressed  in  units  of
enzymatic activity.
Histological processing
Knee joints were removed and fixed in  phosphate-
buffered formalin (10%). The tissues were decalcified
with 5% formic acid solution and thereafter they were
processed  and  embedded  in  paraffin.  Total  joint
sections  (6mm)  were  prepared  and  stained  with
hematoxylin and eosin. Arthritis was assessed semi-
quantitatively in a standardized frontal section of the
knee joint that included the presence of subsynovial
inflammation, destruction of articular cartilage, and
general destruction of the joint with pannus forma-
tion  and  bone  erosion.13 These  parameters  were
scored on a scale of 0–4 as described elsewhere:9–13
0, no abnormalities, normal joint feature; 1, marginal
destruction of cartilage only and slight inflammation
in the articular tissue; 2, extensive inflammation and
moderate cartilage destruction with slight bone ero-
sion, usually on one side of the joint only; 3, extensive
inflammation  and  significant  destruction  of  both
cartilage and bone; and 4, almost complete cartilage
destruction  with  no  intact  cartilage  left,  almost
complete loss of the general joint architecture with
extensive pannus formation and bone erosion, exten-
sive inflammation in  the articular tissue,  mainly  by
mononuclear cells (lymphocytes, plasma cells, macro-
phages), often accompanied by polymorphonuclear
granulocytes.  The  score  given  to  each  joint  is  an
average  for  the  three  histological  sections  through
that joint.
Thus, the pathologist examined the parameters by
a blinded procedure and classified the severity of the
knee  joint  lesions  in  each  mouse  into  five  grades:
grade 0, normal; grade 1, slight; grade 2, moderate;
grade 3, marked; grade 4, severe.
Transmission electron microscopy
Samples  of  articular  cartilage  were  fixed  in  3.2%
glutaraldehyde in cacodilate buffer, post-fixed in 2%
osmium  tetroxide  and  embedded  in  Spurr  resin.14
Sections  were  stained  with  lead  citrate  and  uranil
acetate,15 and observed in a JEOL JEM–100s Electron
Microscope (Japan).
Statistical analysis
Data are presented as mean ± standard deviation. Mean
differences between groups were compared by one-
way analysis of variance with the Duncan’s test. The
level of statistical significance was taken at p < 0.05.
Results
Spirulina effect on zymosan-induced arthritis
Zymosan-induced  arthritis  resulted  in  a  significant
increase  of  b-glucuronidase  levels,  which  were
decreased by Spirulina at doses of 100 and 400mg/kg
per-orally  (p.o.).  This  effect  was  dose  dependent
(Table 1). Triamcinolone almost completely abolished
enhanced  b-glucuronidase  activity  in  the  synovial
fluid of zymosan-treated animals. Daily doses of 100
and 400mg/kg suppressed the enzymatic activity by
78.7 and 89.2%, respectively (Table 1).
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Table 1. Effect of Spirulina on b-glucuronidase activity in mice knee joint synovial fluid
Kind of treatment Doses b-Glucuronidase (U) Inhibition (%)
Saline 0.70 ± 0.25 –
Zymosan 15mg/ml 5.15 ± 1.20 –
Triamcinolone + zymosan 10mg/kg 1.00 ± 0.20* 94.1
Spirulina + zymosan 100mg/kg + 15mg/kg 2.82 ± 0.68* 78.7
Spirulina + zymosan 400mg/kg + 15mg/kg 1.80 ± 0.19* 89.2
Mice were killed 24h after the last administration of Spirulina. It was administered 4 days after zymosan treatment for 12 days. Triamcinolone
was used as a positive control drug in this test. Values are means from groups of 10 mice ± standard error.
*p < 0.05 versus group treated only with zymosan.Histopathological studies
In agreement with these findings, histological evalu-
ation revealed that the group treated with zymosan
showed severe destruction of cartilage with loss of
the general joint architecture and pannus formation.
There was erosion of bone structures accompanied
by severe inflammation of articular tissues (Grades 3
and 4) (Fig. 1a and Table 2).
Spirulina  treatment  (100  and  400mg/kg  p.o.)
revealed a marked decrease of histology score (Grades
1 and 2), the inflammatory reaction was substantially
reduced and there was no destruction of general joint
architecture or pannus formation. Also, a reduction of
bone erosion was observed (Fig. 1b). At the Spirulina
doses  of  100  and  400mg/kg,  60  and  80%  of  the
treated mice, respectively, only showed slight lesions
on the joints (Table 2). Even greater protective effects
were observed with the reference drug, triancinolone
(Table 2).
Ultrastructural studies
Tibial articular cartilage of mice treated with zymosan
showed chondrocytes with ultrastructural changes in
the mitochondria, loss of cristae and swollen matrix.
Separation between collagen fiber bundles were also
observed (Fig. 2a).
On the contrary, the cartilage of mice treated with
zymosan plus Spirulina (400mg/kg p.o.) showed well-
preserved  chondrocytes  with  normal  rough  endo-
plasmic  reticulum.  The  collagen  fibers  present  a
normal arrangement (Fig. 2b).
Discussion
Rheumatoid  arthritis  is  a  chronic  systemic  autoim-
mune  inflammatory  disease  characterized  by  pro-
gressive joint damage and, in its later stages, cartilage
destruction. The current concept of the pathophysiol-
ogy of this disease is that the inflammation and tissue
destruction  result  from  an  unregulated  cascade  of
complex cell-to-cell interactions, initiated by macro-
phage activation and induced by some inflammatory
triggers.16 Zymosan, a product consisting of purified
baker’s yeast ghost cells, induces inflammatory pro-
cesses in which the macrophages play an important
role, and the activation of the synthesis of cytokines
and  various  pro-inflammatory  mediators  such  as
prostaglandins  and  leukotrienes  occurs.17 Zymosan
also activates complement via an alternative pathway,
and induces secretion of lysosomal enzymes and ROS
generation from the macrophages.18 Currently,  it is
recognized that ROS such as OH￿, H2O2 and HOCl are
strongly involved in RA.19
In accordance with these findings, some antioxidant
agents such as N-acetylcysteine,20 ketoprofen21 and
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Table 2. Articular histological lesions of the knee in zymosan-induced arthritis in mice treated with Spirulina
Kind of treatment Dose Grade 0
(%)
Grade 1
(%)
Grade 2
(%)
Grade 3
(%)
Grade 4
(%)
Saline 100 – – – –
Zymosan 15mg/ml – – – 50 50
Triancinolone + zymosan 10mg/kg 90 10 – – –
Spirulina + zymosan 100mg/kg – 60 40 – –
Spirulina + zymosan 400mg/kg – 80 20 – –
Histological studies were read and scored on a scale of 0–4 according to the severity of the lesions: grade 0, normal; grade 1, slight; grade 2,
moderate; grade  3, marked; grade  4, severe. The  animals in each  group were assessed  for lesions.  Triamcinolone was used  as reference
drug.
(a)
(b)
FIG. 1. (a) Histological section of the knee joint infected with
15mg/ml  of  zymosan.  Extensive  pannus  formation  with
erosion of joint cartilage and bone. Hematoxylin and eosin,
100´ .  (b)  Mouse  treated  with  zymosan  plus  Spirulina,
400mg/kg  p.o. Histology of  the knee shows only minimal
inflammatory reaction. Hematoxylin and eosin, 100´ .ebselen22 exerted protective effects in some arthritis
models.
Recently, we reported that phycocyanin has anti-
oxidant properties.6 It was able to scavenge alkoxy
and  hydroxyl  radicals,  and  also  inhibited  hepatic
microsomal lipid peroxidation induced by Fe+2-ascor-
bic  acid,  the  luminol-amplified  chemiluminescent
response of PMNLs stimulated with opsonized zymo-
san. Phycocianin also inhibited, in a dose-dependent
fashion,  the  inflammatory  response  in  zymosan-
induced arthritis in  mice. Furthermore, the bilipro-
tein  also  inhibited  edema  and  leukotriene  B4 and
prostaglandin  E2 generation  in  arachidonic  acid-
induced ear edema in mice.23,24
Taking  into  account  the  former  findings,  it  is
conceivable  that  the  anti-inflammatory  and  anti-
arthritic effects of Spirulina already described may be
due  mainly  to  antioxidant  and  anti-inflammatory
activities  of  its  constituent  phycocyanin.  Some  evi-
dence support this view: (1) in our hands, phycocyanin
exerted protective effects in zymosan-induced arthritis
at doses of 25, 50 and 100mg/kg p.o., whereas under
the same experimental conditions Spirulina exerted its
inhibitory effects in this model at greater doses (100
and 400mg/kg, p.o.), which correlates with 20–25%
that  represents  phycocyanin  in  the  composition  of
Spirulina;10(2) our results do not provide any evidence
in favor of pharmacological synergism of phycocyanin
with other constituents of Spirulina with antioxidant
and anti-inflammatory properties such as b-carotene,
phenolic  compounds  and  the  essential  polyunsatu-
rated  fatty  acids.  However,  these  substances  are
available in  Spirulina  in  much  lower concentrations
than phycocyanin.5,25 Nevertheless, a minor contribu-
tion of  the former compounds to anti-inflammatory
effects of Spirulina cannot be excluded.
In  conclusion,  Spirulina  exerts  anti-inflammatory
effects  in  experimental  arthritis  and,  taking  into
account that the microalgae is commonly used as food
supplement  and its safety as human food has been
established through various toxicological studies,26,27
we believe that Spirulina  merits further  pre-clinical
and clinical studies to determine its place as potential
drug  for  the  treatment of  rheumatoid arthritis and
other inflammatory diseases.
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FIG. 2. (a) Transmission electron microscopy image of tibial
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the collagen fibrils package is shown. 12,000´ . (b) Transmis-
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